CN106511262A — 一种泊沙康唑口服溶液剂及其制备方法
Assigned to Wuhan Lang Lai Development In Science And Technology Co Ltd · Expires 2017-03-22 · 9y expired
What this patent protects
本发明公开了一种泊沙康唑口服溶液剂及其制备方法。其原料含有泊沙康唑、羟丙基-β-环糊精、矫味剂、pH调节剂、缓冲对、防腐剂和水。制备方法为：将占处方量0-6％的泊沙康唑、占处方量20-60％的羟丙基-β-环糊精和缓冲液混匀，得溶液①；缓冲液由占处方量40％的缓冲对加水稀释制得；将溶液①与剩余羟丙基-β-环糊精混匀，用pH调节剂调节pH至2-3，得溶液②；将溶液②与剩余泊沙康唑混匀，用pH调节剂调节pH至2-3，混匀，用pH调节剂调节pH至4-4.5，得溶液③；将溶液③与剩余缓冲对混匀，再与矫味剂和防腐剂混匀，用水补足，混匀。所述泊沙康唑口服溶液剂的稳定性…
USPTO Abstract
本发明公开了一种泊沙康唑口服溶液剂及其制备方法。其原料含有泊沙康唑、羟丙基-β-环糊精、矫味剂、pH调节剂、缓冲对、防腐剂和水。制备方法为：将占处方量0-6％的泊沙康唑、占处方量20-60％的羟丙基-β-环糊精和缓冲液混匀，得溶液①；缓冲液由占处方量40％的缓冲对加水稀释制得；将溶液①与剩余羟丙基-β-环糊精混匀，用pH调节剂调节pH至2-3，得溶液②；将溶液②与剩余泊沙康唑混匀，用pH调节剂调节pH至2-3，混匀，用pH调节剂调节pH至4-4.5，得溶液③；将溶液③与剩余缓冲对混匀，再与矫味剂和防腐剂混匀，用水补足，混匀。所述泊沙康唑口服溶液剂的稳定性和生物利用度高，方便服用。
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.